Pharmacist-led Services Research Articles

Liability for Errors in Expanded Pharmacy Practice: Issues for Technicians and Pharmacists: Medication errors should be viewed as•an opportunity to identify system problems and generate solutions-not to assign individual blame.

Industry trends, such as the growth of managed care and pharmacist-led cognitive services, have led to greater reliance on pharmacy technicians. In a recent USP study of medication errors, the dispensing function was the function in which technician errors were most likely to occur. Pharmacists and technicians must work as a team to reduce medication errors and improve quality assurance. Medication errors provide an opportunity to identify system problems, generate solutions, and implement corrective measures.

Patient Assessment Tools: Utilizing Diagnostic and Monitoring Devices: As the trend toward pharmacy-based screening and monitoring grows, an increasing array of compact, convenient, and accurate patient assessment tools is available.

Pharmacists are becoming increasingly involved in the detection and monitoring of chronic disease states. A growing number of chronic diseases can be screened and monitored by pharmacists, including diabetes, dyslipidemias, hypertension, and osteoporosis. Devices for screening and monitoring are becoming less complex and more convenient, allowing for greater use in pharmacies and, in many cases, for patients use at home. The provision of pharmacist-led assessment services is becoming more widely accepted by patients, physicians, and some third-party payers.

Patient Assessment Tools: Utilizing Diagnostic and Monitoring Devices: As the trend toward pharmacy-based screening and monitoring grows, an increasing array of compact, convenient, and accurate patient assessment tools is available.

Pharmacists are becoming increasingly involved in the detection and monitoring of chronic disease states. A growing number of chronic diseases can be screened and monitored by pharmacists, including diabetes, dyslipidemias, hypertension, and osteoporosis. Devices for screening and monitoring are becoming less complex and more convenient, allowing for greater use in pharmacies and, in many cases, for patients use at home. The provision of pharmacist-led assessment services is becoming more widely accepted by patients, physicians, and some third-party payers.